Rheumatoid Arthritis

Top Story

IBD risk increases with Enbrel therapy for other autoimmune diseases

July 18, 2019
In the Journals

Baricitinib improves RA in patients unresponsive to methotrexate

July 16, 2019
Baricitinib monotherapy improves disease control in many patients with rheumatoid arthritis who were did not respond to methotrexate, according to data published in…
In the Journals

Genetic risk for RA associated with early cognitive symptoms in children

July 8, 2019
Having an increased genetic risk for rheumatoid arthritis is associated with demonstrating hyperactivity and inattention symptoms from ages 4 to 16 years, as well as…
In the Journals

Abatacept, TNF inhibitors similar in 9-year persistence rates in RA

July 2, 2019
Abatacept demonstrated similar 9-year persistence rates as TNF inhibitors when used as a first-line treatment for rheumatoid arthritis, and had superior persistence…
More Headlines »
CME

Rheum360: Focus on Biosimilars

This activity is supported by an independent medical education grant from Sandoz Inc., a Novartis Division.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »
Video
Meeting News

Heterogeneity still major challenge in connective tissue diseases

May 6, 2019
More »
CME

Virtual RA Forum®: Applying Recent Advances to Improve Quality Care

This activity is supported by an educational grant from Pfizer, Inc.

Rheumatoid arthritis (RA) is a progressive and painful systemic inflammatory disease that preferentially attacks the…
More »